SLGL Stock Analysis: Buy, Sell, or Hold?
SLGL - Sol-Gel Technologies Ltd. Ordinary Shares
$64.22
3.37 (5.54%)
▲
5d:
+9.89%
30d:
+51.25%
90d:
+73.57%
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 11, 2026
Get Alerted When SLGL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SLGL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: SLGL shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SLGL is currently trading at $64.22, which is considered slightly high relative to its 30-day fair value range of $47.02 to $66.12.
Technical Outlook: Technically, SLGL is in a strong uptrend. Immediate support is located at $48.26, while resistance sits at $75.00. The stock is showing strong short-term momentum, up 5.5% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $50.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SLGL is in a strong uptrend. Immediate support is located at $48.26, while resistance sits at $75.00. The stock is showing strong short-term momentum, up 5.5% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. However, the stock is trading significantly above the average Wall Street target of $50.00. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$47.02 -
$66.12
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.6%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.5%)
- BEARISH: Trading 22.1% above Wall St target ($50.00)
Fair Price Analysis
30-Day Fair Range
$47.02 -
$66.12
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$48.26
Resistance Level
$75.00
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-9.73
Wall Street Target
$50.00
(-22.1%)
Revenue Growth (YoY)
217.7%
Earnings Growth (YoY)
487.6%
Profit Margin
-14.2%
Last updated: February 02, 2026 6:21 AM ET
Data refreshes hourly during market hours. Next update: 7:21 AM
Data refreshes hourly during market hours. Next update: 7:21 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLGL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
